Evidence map›Paper›PMID 36551510›Full record

ArticleCancers2022

Prognostic Significance of p16 and Its Relationship with Human Papillomavirus Status in Patients with Penile Squamous Cell Carcinoma: Results of 5 Years Follow-Up.

Jad Chahoud, Niki M Zacharias, Rachel Pham, Wei Qiao, Ming Guo, Xin Lu, Angelita Alaniz, Luis Segarra, Magaly Martinez-Ferrer, Frederico Omar Gleber-Netto and 3 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
7.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Jad ChahoudDepartment of Genitourinary Oncology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.
Niki M ZachariasDepartment of Urology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Rachel PhamDepartment of Urology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Wei QiaoDepartment of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.ORCID 0000-0002-0922-0726
Ming GuoDepartment of Pathology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Xin LuDepartment of Biological Sciences, University of Notre Dame, Notre Dame, IN 46556, USA.ORCID 0000-0002-0284-6478
Angelita AlanizCenter for Health Promotion and Prevention Research, University of Texas Health Science Center at Houston, Houston, TX 77030, USA.
Luis SegarraDepartment of Urology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Magaly Martinez-FerrerDepartment of Pharmaceutical Sciences, University of Puerto Rico Medical Sciences Campus & Cancer Biology, UPR Comprehensive Cancer Center, San Juan, PR 00936, USA.
Frederico Omar Gleber-NettoDepartment of Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.ORCID 0000-0001-7847-9902
Curtis R PickeringDepartment of Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Priya RaoDepartment of Pathology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Curtis A PettawayDepartment of Urology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
The University of Texas MD Anderson Cancer Center · USMoffitt Cancer Center · USThe University of Texas Health Science Center at Houston · USUniversity of Notre Dame · USUniversity of Puerto Rico, Medical Sciences Campus · PR

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Fabien Delerue · 1985 to 2026
$290.8M
UPR/MDACC Partnership for Excellence in Cancer Research(Parent Grant U54 CA096297)U54CA096297 · NCI · UNIVERSITY OF PUERTO RICO MED SCIENCES · PI SHARON Hermes GIORDANO, REYNOLD Eugenio LOPEZ-ENRIQUEZ · 2002 to 2026
$36.9M
UPR/MDACC Partnership for Excellence in Cancer Research (Luis Segarra supplement)U54CA096300 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI SHARON Hermes GIORDANO · 2002 to 2026
$23.8M
NCI NIH HHS 2P30CA016672-38NCI NIH HHS U54 CA096297NCI NIH HHS U54 CA096300NCI NIH HHS U54CA096300/U54CA096297
6 · The paper itself

Abstract

Penile Squamous Cell Carcinoma (PSCC) is associated with high-risk human papillomavirus (HR-HPV). The immunohistochemical (IHC) test for p16

Indexed as

cancer specific survivalCDKN2Ahuman papillomavirusoverall survivalp16penile squamous cell carcinoma

Identifiers

PMID36551510
PMCPMC9775956
OpenAlexW4311786355

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.